Compare Lustrum:UMN Pharma Inc.:4585

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index UMN Pharma Inc. 4585 Medicals TSE December 1, 2000 2012.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

UMN Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

UMN Pharma Inc. Balance Sheet 2018年12月期 UMN Pharma Inc. Balance Sheet 2017年12月期 UMN Pharma Inc. Balance Sheet 2016年12月期 UMN Pharma Inc. Balance Sheet 2015年12月期 UMN Pharma Inc. Balance Sheet 2014年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2018 December 31, 2017 December 31, 2016 December 31, 2015 December 31, 2014
Cash and Cash Equivalents
(Percent)
1,018down
(86.5%)down
1,734up
(91.7%)up
978up
(64.7%)up
842down
(7.1%)down
2,080
(16.1%)
Other Current AssetsHelp
(Percent)
59down
(5.0%)down
103down
(5.4%)down
478down
(31.6%)up
2,462up
(20.8%)up
1,117
(8.7%)
Tangible Fixed AssetsHelp
(Percent)

-

-

-

-

-
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
1down
(0.1%)down
172down
(1.5%)down
246
(1.9%)
Investments and OthersHelp
(Percent)
19down
(1.6%)down
54
(2.9%)down
54down
(3.6%)up
196down
(1.7%)down
268
(2.1%)
Total AssetsHelp
(Percent)
1,177
(100%)
1,891
(100%)
1,511
(100%)
11,808
(100%)
12,882
(100%)
Total Current LiabilitiesHelp
(Percent)
80up
(6.8%)up
74down
(3.9%)down
8,051up
(532.8%)up
5,913up
(50.1%)up
2,390
(18.6%)
Total Long-term LiabilitiesHelp
(Percent)
715down
(60.7%)down
1,460down
(77.2%)down
4,381down
(289.9%)up
5,562down
(47.1%)down
6,787
(52.7%)
Shareholder's EquityHelp
(Percent)
382up
(32.5%)up
357up
(18.9%)up
-10,921down
(-722.8%)down
333down
(2.8%)down
3,705
(28.8%)
Total LiabilitiesHelp
(Percent)
1,177
(100%)
1,891
(100%)
1,511
(100%)
11,808
(100%)
12,882
(100%)

UMN Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

UMN Pharma Inc. Profit and Loss Account 2018年12月期 UMN Pharma Inc. Profit and Loss Account 2017年12月期 UMN Pharma Inc. Profit and Loss Account 2016年12月期 UMN Pharma Inc. Profit and Loss Account 2015年12月期 UMN Pharma Inc. Profit and Loss Account 2014年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2018 December 31, 2017 December 31, 2016 December 31, 2015 December 31, 2014
Amount of Sales
(Percent)
104
(100%)
104
(100%)
71
(100%)
203
(100%)
1,109
(100%)
Total Sales
(Percent)
104
(100%)
104
(100%)
71
(100%)
203
(100%)
1,109
(100%)
Cost of SalesHelp
(Percent)
2down
(1.9%)down
3down
(2.9%)down
39down
(54.9%)up
53down
(26.1%)up
174
(15.7%)
Other Costs and RevenueHelp 831up
(799.0%)up
260down
(250.0%)down
14,131up
(19,902.8%)up
3,540down
(1,743.8%)up
4,896
(441.5%)
Total CostsHelp 833 263 14,170 3,593 5,070
Net RevenueHelp 102up
(98.1%)up
101up
(97.1%)up
32down
(45.1%)down
150down
(73.9%)down
935
(84.3%)
Earnings Before TaxHelp -609down
(-585.6%)down
-158up
(-151.9%)up
-3,857down
(-5,432.4%)down
-3,390up
(-1,670.0%)down
-4,249
(-383.1%)
Net IncomeHelp -729down
(-701.0%)down
-159up
(-152.9%)up
-14,099down
(-19,857.7%)down
-3,390up
(-1,670.0%)down
-3,961
(-357.2%)
当期純利益 -729 -159 -14,099 -3,390 -3,961

UMN Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

UMN Pharma Inc. Cash Flow Statement 2018年12月期 UMN Pharma Inc. Cash Flow Statement 2017年12月期 UMN Pharma Inc. Cash Flow Statement 2016年12月期 UMN Pharma Inc. Cash Flow Statement 2015年12月期 UMN Pharma Inc. Cash Flow Statement 2014年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2018 December 31, 2017 December 31, 2016 December 31, 2015 December 31, 2014
Operating Cash Flow(OFC)Help
(Percent)
-578down
(-80.7%)down
-562up
(-32.5%)up
-2,265up
(-53.4%)up
-3,394down
(-89.5%)down
315
(12.6%)
Investing Cash Flow(ICF)Help
(Percent)
-134
(-18.7%)
0
-
-1,842down
(-43.4%)down
-398down
(-10.5%)down
-9
(-0.4%)
Financing Cash FlowHelp
(Percent)
-4down
(-0.6%)down
1,730down
(100.0%)
4,243up
(100.0%)up
2,554up
(67.4%)up
-2,493
(-99.6%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn -716down
(-100.0%)down
1,168up
(67.5%)up
136up
(3.2%)up
-1,238up
(-32.6%)up
-2,187
(-87.4%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

UMN Pharma Inc.

Company where related level is highHelp

CHUGAI PHARMACEUTICAL CO., LTD.
CanBas Co.,Ltd.
Oncolys BioPharma Inc.
Mitsubishi Tanabe Pharma Corporation
LTT Bio-Pharma Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
SanBio Company Limited
SAWAI GROUP HOLDINGS Co., Ltd.
Kyowa Kirin Co.,Ltd.
Chiome Bioscience Inc.